Clinical TrialsSearch results
Number of results: 857
Other
- Phase III Clinical Study on ART-123 in patients with disseminated intravascular coagulation (DIC) directly caused by malignant hematopoietic tumors or infections (Multicenter double-blind randomized parallel group comparative study with heparin sodium as control drug)
- Disseminated intravascular coagulation (DIC) directly caused by malignant hematopoietic tumors or infections
- Asahi Kasei Pharma Corporation
- 2006-02-07
Other
- Phase II trial of endoscopic submucosal dissection to expand indication for early gastric cancer (JCOG0607)
- clinical T1 gastric cancer without submucosal invasion
- Japan Clinical Oncology Group (JCOG)
- 2007-06-08
Other
- Phase II trial of chemoradiotherapy concurrent with S-1 plus cisplatin in patients with unresectable locally advanced squamous cell carcinoma of the head and neck (JCOG0706)
- unresectable locally advanced squamous cell carcinoma of the head and neck
- Japan Clinical Oncology Group (JCOG)
- 2008-07-28
Other
- Phase II study with tacrolimus to prevent GVHD for reduced-intensity peripheral blood stem cell transplantation from an HLA-identical related donor
- Acute leukemia, Chronic leukemia, Myelodysplastic syndrome, Malignant lymphoma, Adult T cell leukemia/lymphoma
- Nagoya Blood and Marrow Transplantation Group
- 2008-06-01
Other
- Phase II study of weekly irinotecan (CPT-11) for relapsed and/or refractory multiple myeloma
- relapsed and/or refractory multiple myeloma after treatment with bortezomib or thalidomide (lenalidomide) in addition to the prior treatment with melphalan
- Nagoya City University Hospital
- 2008-07-01
Other
- Phase II study of TS-1 chemotherapy as adjuvant treatment after resection of hepatic metastases from colorectal cancer
- liver metastases of colorectal cancer
- Nagoya Surgical Oncology Group
- 2008-11-12
Other
- Phase II Study of Thymomectomy for Thymoma Localized in the Thymus
- thymoma
- Japanese Association for Research on the Thymus
- 2007-04-01
Other
- Phase II study of SMILE chemotherapy for stage IV or relapsed/refractory extranodal NK/T-cell lymphoma
- extranodal NK/T-cell lymphoma, nasal type
- NK-cell Tumor Study Group
- 2007-05-14
Other
- Phase II study of S-1 in patients with gemcitabine-refractory advanced biliary tract cancer
- Patients with gemcitabine-refractory advanced biliary tract cancer
- National Cancer Center Hospital East Hepatobiliary and Pancreatic Oncology Division
- 2007-12-01
Other
- Phase II study of rituximab in refractory or relapsed patients with multiple myeloma expressing CD20
- Multiple myeloma expressing CD20
- Zenyaku Kogyo Co., Ltd.
- 2006-11-28